Eckert & Ziegler Strahlen- und Medizintechnik AG

Legal Proceedings Report • Jan 20, 2010

News Details

Corporate | 20 January 2010 12:04

Eckert & Ziegler: Court Confirms Mandatory Take-Over Bid for IBt

Eckert & Ziegler Strahlen- und Medizintechnik AG / Legal Matter

20.01.2010

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, January 20, 2010 - The Court of Appeal in Brussels has rejected
Eckert & Ziegler's (ISIN DE0005659700) appeal against an injunction of
Belgian financial regulator CBFA and confirmed the legitimacy of the
requested mandatory take-over bid. It also asked Eckert & Ziegler to pay
litigation cost in the amount of 20,186 EUR. The court decision is
otherwise not expected to have material consequences for the current
take-over bid, and will not affect, for example, the price or the valuation
of IBt. Eckert & Ziegler had already voluntarily included the requests of
the Belgian financial regulator into its offer. Since the verdict denies a
material interest for the claim of Creafund, Eckert & Ziegler assumes that
the decision will actually conclude all litigation related to the take-over
bid.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str.
10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de,
www.ezag.com

20.01.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Deutschland
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700, DE000A0L1L69
WKN: 565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Düsseldorf, Hamburg

End of News DGAP News-Service

---